|
⚲
|
| Keyboard |
| Epperly Melissa B
✚
|
|
|---|---|
| CIK # | 0001807359 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001807359] | |
| 4 | [0001807359] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Epperly Melissa B | |
| Roivant Sciences Ltd | |
| ARYA Sciences Acquisition Corp III | |
| Kinnate Biopharma Inc | |
| Zentalis Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-03-16 | Sell | 41,861 | $28.68 | 1,200,573 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-01-20 | Tax withheld | 54 | $22.98 | 1,241 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-01-20 | Grant | 815 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-10-20 | Grant | 1,056 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-07-17 | Grant | 1,609 | $0.00 | |
|
ARYA Sciences Acquisition Corp III NAUT
Stock Option (Right to Buy) · derivative
|
2025-06-23 | Grant | 45,000 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-04-17 | Grant | 1,847 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-01-23 | Grant | 1,672 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-01-23 | Tax withheld | 180 | $11.21 | 2,018 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2024-10-21 | Grant | 1,613 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2024-09-12 | Other | 4,245 | $12.12 | 51,449 |
|
Roivant Sciences Ltd ROIV
Stock Option (Right to Buy) · derivative
|
2024-09-10 | Grant | 27,894 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2024-09-10 | Grant | 16,406 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2024-07-23 | Grant | 1,702 | $0.00 | |
|
ARYA Sciences Acquisition Corp III NAUT
Stock Option (Right to Buy) · derivative
|
2024-06-14 | Grant | 45,000 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2024-04-24 | Grant | 1,146 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2024-04-24 | Tax withheld | 123 | $10.90 | 1,341 |
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 20,250 | ||
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 60,751 | ||
|
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
|
2024-04-03 | Disposed to issuer | 20,250 | ||
| showing 20 of 92 most recent transactions | |||||